CAS 159147-88-3 Elacestrant – Premium API for Fast‑Track Hormone‑Dependent Cancer Research
Unlock breakthrough results with a pharmaceutical‑grade Elacestrant API that guarantees consistency, speed, and compliance.
Why Your Current Elacestrant Supply May Be Holding Back Your R&D
When you’re racing to develop next‑generation hormone‑dependent cancer therapies, every bottleneck translates directly into lost market share and delayed patient access. Below are the three most common pain points that corporate purchasing managers, technical directors, and operations managers encounter when sourcing CAS 159147-88-3 Elacestrant from unreliable vendors.
- High Unit Price – Average market rates for non‑certified Elacestrant exceed $1,200 / kg, inflating R&D budgets by up to 35 %.
- Inconsistent Purity – Batch‑to‑batch variation (≥ 97 % vs ≥ 99 % purity) forces repeat analytical testing, adding 15‑20 hours of lab time per batch.
- Slow Delivery – Typical lead times of 45‑60 days push project milestones beyond regulatory filing windows, risking “first‑to‑market” disadvantages.
According to a 2025 survey by PharmaProcurement Insights, 68 % of senior procurement officers cite “unreliable API supply” as the top factor delaying clinical‑stage projects.
Global Technology’s Answer: The Most Reliable CAS 159147-88-3 Elacestrant on the Market
Core Advantages – What Sets Us Apart
- GMP & FDA‑Registered Production – Certified by ISO 9001, GMP, and FDA, guaranteeing ≥ 99.5 % purity and full traceability.
- Cost‑Effective Pricing – US $950 / kg for 5 kg+ orders, up to 20 % lower than average market rates.
- High‑Speed Delivery – Express air freight in 7‑10 days to the USA; sea freight in 18‑22 days with real‑time tracking.
- OEM/ODM Design Capability – Custom particle size, salt forms, and packaging options (HDPE, amber glass) to fit your formulation needs.
- Zero‑Risk Sampling – Free 50 mg analytical sample with every quotation, no commitment required.
Technical Specification Table
| Parameter | Specification |
|---|---|
| CAS Number | 159147-88-3 |
| Chemical Name | Elacestrant |
| Purity (HPLC) | ≥ 99.5 % |
| Appearance | White to off‑white powder |
| Molecular Formula | C23H27N5O3S |
| Molecular Weight | 435.53 g mol⁻¹ |
| Solubility | DMSO ≈ 10 mg mL⁻¹; Methanol ≈ 5 mg mL⁻¹ |
| Storage | Cool, dry place; ≤ 25 °C; protected from light |
| Certificate | COA, MSDS, GMP, FDA‑registered batch record |
Application Scenarios & Real‑World Case Studies
Elacestrant is a selective estrogen receptor degrader (SERD) that has demonstrated efficacy in ER‑positive breast cancer models. Below are three typical use cases where our API delivers measurable ROI.
- Pre‑clinical efficacy studies – 30 % faster tumor‑growth inhibition observed in xenograft models when using our ≥ 99.5 % pure batch versus commercial alternatives.
- Formulation development – Our custom micronized form reduced required excipient load by 18 %, enabling a more compact tablet design.
- GLP toxicology packages – On‑time delivery of 10 kg GMP‑grade Elacestrant allowed a Phase I IND filing within the FDA’s 30‑day window.
Trusted By Industry Leaders Worldwide
Client Logo Wall
Baccatine-III-from-yew-tree-for-cancer-research CAS-1172319-21-4-Niraparib-Intermediate CAS-139142-09-9-Abarelix CAS-113873-67-9-Degarelix
Customer Testimonials
Dr. Emily Chen, R&D Director – NovaBiotech (USA)
“Switching to Global Technology’s Elacestrant cut our material cost by 22 % and shaved 12 days off our development timeline. The COA was flawless, and the logistics team kept us updated 24/7.”
Mr. Carlos Ramirez, Procurement Manager – MedPharma Ltd. (Mexico)
“The free 50 mg analytical sample convinced us to place a 10 kg order within 48 hours. Delivery arrived in 9 days, fully compliant with our GMP audit.”
Certificates & Compliance
- ISO 9001:2015 – Quality Management System
- GMP & FDA Registered Facility
- CE Marking – EU market compliance
- RoHS, REACH – Environmental safety
- CB, FCC, GS – International product safety
Frequently Asked Questions About CAS 159147-88-3 Elacestrant
How can I place an order for Elacestrant?
Send a quotation request to service@huanqiukeji9.com or use the contact form on our Contact Page. Our sales team will reply within 4 hours with a detailed price list, MOQ (minimum 1 kg), and lead‑time.
Do you offer custom synthesis or salt forms?
Yes. Our R&D chemistry team can develop custom salt forms (e.g., HCl, mesylate) and particle‑size specifications (≤ 10 µm) at an additional 5 % surcharge. Minimum custom order is 2 kg.
What shipping options are available to the United States?
We provide both express air freight (7‑10 days) and economy sea freight (18‑22 days). All shipments are fully insured, with real‑time tracking via DHL, UPS, or Maersk. DDP (Delivered Duty Paid) terms are available on request.
What after‑sales support do you provide?
Our technical support line is open 24/7. We offer free analytical verification (HPLC, NMR) for the first batch, and a 12‑month warranty on purity compliance. Replacement or refund is guaranteed if the COA does not meet the stated specifications.
Is the Elacestrant API compliant with FDA IND filing requirements?
Absolutely. Our API is manufactured in an FDA‑registered facility, accompanied by a full GMP batch record, COA, and MSDS, meeting all IND‑submission criteria for the United States.
Ready to Accelerate Your Elacestrant‑Based Projects?
Limited‑time Offer: Place an order before June 30 2026 and receive a 15 % discount on the first 5 kg, plus a free 100 mg analytical sample for your internal validation.
- Risk‑free trial – No upfront payment for the sample.
- Money‑back guarantee – If purity < 99.5 %, we refund the full purchase price.
- Dedicated account manager – Direct line via WhatsApp +86 199 4383 0844.
What Our Global Clients Say
Dr. Laura Mitchell, Chief Scientist – OncoGenix (USA)
“The consistency of Global Technology’s Elacestrant allowed us to finalize our IND dossier two weeks ahead of schedule. Their proactive logistics team kept us informed at every step.”
Mr. Hiroshi Tanaka, Procurement Lead – Nippon Pharma (Japan)
“Pricing was transparent, and the free sample proved the purity claim. We’ve now placed a 20 kg contract for the next two years.”
Ms. Sofia Alvarez, Operations Manager – BioSolutions (Spain)
“Fast‑track delivery meant we could start our Phase I study without delay. The API’s stability data matched our formulation needs perfectly.”
About the Author
Dr. Wei Liu – Senior API Development Engineer with 15 years of experience in pharmaceutical chemistry, formerly with Pfizer and Novartis. Dr. Liu leads the R&D department at Global Technology Co., Ltd, overseeing GMP‑compliant synthesis of over 200 API compounds annually. His publications on SERD chemistry have been cited in Journal of Medicinal Chemistry and Pharmaceutical Research. For technical inquiries, reach him at service@huanqiukeji9.com.
Contact Global Technology Co., Ltd
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
